Vanzacaftor
Vanzacaftor is a novel CFTR (Cystic fibrosis transmembrane conductance regulator) corrector.
Systematic Name
(14S)-8-[3-(2-Dispiro[2.0.24.13]Heptan-7-Ylethoxy)Pyrazol-1-Yl]-12,12-Dimethyl-2,2-Dioxo-2λ6-Thia-3,9,11,18,23-Pentazatetracyclo[17.3.1.111,14.05,10]Tetracosa-1(22),5(10),6,8,19(23),20-Hexaen-4-One
Brand Name(S)
N/A
Therapeutic Category
Cystic fibrosis
Suitable Formulations
Solid
Approvals
U/Development